SCHEMBL23536304

SCHEMBL23536304

CN(C)S(=O)(=O)c1ccc(S(=O)(=O)N2CC[C@H](N3CCC(c4ccc(Cl)cc4F)CC3)C2=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PROKR1 Q8TCW9 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
OPRL1 P41146 2/20 0.35
SLC9A1 P19634 1/20 0.35
MMP2 P08253 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CTSG P08311 1/20 0.33
CMA1 P23946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29931878 1.00 LMNA (0.37) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL29931931 0.87 DRD2 (0.36) PROKR1OPRL1
SCHEMBL29932243 0.74 LMNA (0.38) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL23536043 0.74 LMNA (0.38) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL29932092 0.73 LMNA (0.41) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL23536355 0.73 LMNA (0.41) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL23536117 0.72 POLB (0.41) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL29931921 0.72 POLB (0.41) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL23536124 0.72 TSHR (0.39) LMNATP53GAAHTTSMN1; SMN2
SCHEMBL29931867 0.72 TSHR (0.39) LMNATP53GAAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127337-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed